Correlations between counts of lymphocytes, neutrophils, and C-reactive protein, and the efficacy of nivolumab (nivo) monotherapy in non-small cell lung cancer patients
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics; Therapeutic Use
- 13 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology